This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:pathogenesis:th1spectrum [02.10.2019] – [Metabolic syndrome] sallieq | home:pathogenesis:th1spectrum [01.13.2024] (current) – [Comorbidity of inflammatory diseases] ron | ||
---|---|---|---|
Line 23: | Line 23: | ||
< | < | ||
- | //**A. Gonzalez** et al.//(({{pubmed> | + | //**A. Gonzalez** et al.//(({{pmid> |
</ | </ | ||
- | When the Th1 pathogens compromise the immune response, they make it easier for other types of bacteria in other locations to infect the body as well. This phenomenon is known as comorbidity. Although a comorbid condition is [[http:// | + | When the Th1 pathogens compromise the immune response, they make it easier for other types of bacteria in other locations to infect the body as well. This phenomenon is known as comorbidity. Although a comorbid condition is [[https:// |
Epidemiological research may have its share of liabilities, | Epidemiological research may have its share of liabilities, | ||
+ | < | ||
The following wheel shows how truly related chronic diseases are. Each " | The following wheel shows how truly related chronic diseases are. Each " | ||
- | |||
Line 363: | Line 363: | ||
< | < | ||
</ | </ | ||
+ | The following paragraph contains links to all the studies alluded to in the above chart. | ||
+ | </ | ||
+ | Please note that some of the disease names in the following paragraph are links to articles discussing those diseases in further detail. | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | anxiety disorders (({{pmid> | ||
+ | arthritis (({{pmid> | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | cardiovascular disease (({{pmid> | ||
+ | [[home: | ||
+ | [[home: | ||
+ | chronic obstructive pulmonary disease (({{pmid> | ||
+ | [[home: | ||
+ | [[home: | ||
+ | diabetes, type1 (({{pmid> | ||
+ | diabetes, type2 (({{pmid> | ||
+ | [[home: | ||
+ | Guillain-Barré syndrome (({{pmid> | ||
+ | hypertension (({{pmid> | ||
+ | inflammatory bowel disease ([[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | myasthenia gravis (({{pmid> | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | [[home: | ||
+ | Sjogren' | ||
+ | thyroiditis ([[home: | ||
+ | [[home: | ||
+ | vitiligo (({{pmid> | ||
+ | |||
+ | ==== Multimorbidity ==== | ||
+ | [{{ : | ||
- | The following paragraph contains links to all the studies alluded to in the above chart. Please note that some of the disease names are links to articles discussing those diseases in further detail. | ||
+ | According to a 2012 //JAMA// paper, the most common chronic condition experienced by adults is multimorbidity, | ||
- | < | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | anxiety disorders (({{pubmed> | ||
- | arthritis (({{pubmed> | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | cardiovascular disease (({{pubmed> | ||
- | [[home: | ||
- | [[home: | ||
- | chronic obstructive pulmonary disease (({{pubmed> | ||
- | [[home: | ||
- | [[home: | ||
- | diabetes, type1 (({{pubmed> | ||
- | diabetes, type2 (({{pubmed> | ||
- | [[home: | ||
- | Guillain-Barré syndrome (({{pubmed> | ||
- | hypertension (({{pubmed> | ||
- | inflammatory bowel disease ([[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | myasthenia gravis (({{pubmed> | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | [[home: | ||
- | Sjogren' | ||
- | thyroiditis ([[home: | ||
- | [[home: | ||
- | vitiligo (({{pubmed> | ||
+ | To control for confounding variables, researchers often exclude patients with more than one condition from research studies even though they represent the majority of patients.(({{pmid> | ||
- | < | ||
- | </ | ||
+ | A recent survey of Marshall Protocol patients, discussed in [[home: | ||
- | + | ==== Metabolic syndrome | |
- | ==== Multimorbidity | + | |
+ | Impact of 25-hydroxyvitamin D, free and bioavailable fractions of vitamin D, and vitamin D binding protein levels on metabolic syndrome components | ||
+ | |||
+ | ===== Intestinal barrier ===== | ||
- | [{{ :home: | + | Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, |
- | + | The two major triggers | |
- | According to a 2012 //JAMA// paper, the most common chronic condition experienced by adults is multimorbidity, | + | |
- | + | ||
- | + | ||
- | To control for confounding variables, researchers often exclude patients with more than one condition from research studies even though they represent the majority of patients.(({{pubmed>long:22935268}})) Jeste //et al// made this observation in patients with schizophrenia(({{pubmed> | + | |
- | + | ||
- | + | ||
- | A recent survey of Marshall Protocol patients, discussed in [[home: | + | |
===== The challenge of diagnosing diseases caused by bacteria ===== | ===== The challenge of diagnosing diseases caused by bacteria ===== | ||
Line 448: | Line 448: | ||
==== No consistent symptom presentation ==== | ==== No consistent symptom presentation ==== | ||
- | Medicine has difficulty diagnosing disorders where there is no consistently identified anatomic abnormality or documented metabolic/ | + | Medicine has difficulty diagnosing disorders where there is no consistently identified anatomic abnormality or documented metabolic/ |
Line 464: | Line 464: | ||
Another challenge relates to how diseases are segmented into categories even when the nature of the diseases themselves don't warrant such fine-graded distinctions. | Another challenge relates to how diseases are segmented into categories even when the nature of the diseases themselves don't warrant such fine-graded distinctions. | ||
- | One who pores through the articles of a medical textbook could easily form the impression that diseases are discrete, well-defined and mutually exclusive. The reality is that the nature of illness is such that diagnosis is often inexact. Over the past few decades, the [[http:// | + | One who pores through the articles of a medical textbook could easily form the impression that diseases are discrete, well-defined and mutually exclusive. The reality is that the nature of illness is such that diagnosis is often inexact. Over the past few decades, the [[https:// |
To resolve this ambiguity, epidemiologists have developed a kind of stop-gap measure: rubrics - many of them " | To resolve this ambiguity, epidemiologists have developed a kind of stop-gap measure: rubrics - many of them " | ||
Line 478: | Line 478: | ||
Absolute certainty in diagnosis is unattainable, | Absolute certainty in diagnosis is unattainable, | ||
- | //**Jerome Kassirer, MD**// (({{pubmed> | + | //**Jerome Kassirer, MD**// (({{pmid> |
- | In practice, as one approaches diagnostic certainty the useful information returned by diagnostic tests and observations approaches zero.(({{pubmed> | + | In practice, as one approaches diagnostic certainty the useful information returned by diagnostic tests and observations approaches zero.(({{pmid> |
A 2011 article in the Daily Beast showed how some common tests and procedures may do more harm than good. | A 2011 article in the Daily Beast showed how some common tests and procedures may do more harm than good. | ||
Line 493: | Line 493: | ||
A corollary of this principle is that attempts to compare one patient' | A corollary of this principle is that attempts to compare one patient' | ||
- | |||
- | |||
- | |||
- | ==== Metabolic syndrome ==== | ||
- | |||
- | Impact of 25-hydroxyvitamin D, free and bioavailable fractions of vitamin D, and vitamin D binding protein levels on metabolic syndrome components | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | ===== Intestinal barrier ===== | ||
- | |||
- | Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, | ||
- | |||
- | The two major triggers of zonulin release that have been described so far are bacteria and gliadin. It is well described that many enteric pathogens are able to produce enterotoxins that affect the intestinal tight junction of the host. | ||
- | |||
Line 519: | Line 502: | ||
{{tag> | {{tag> | ||
+ | < | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
+ | |||
+ | |||
+ | | ||
--- //Sallie Q 11.28.2016// | --- //Sallie Q 11.28.2016// | ||
Line 532: | Line 519: | ||
Studies to add: | Studies to add: | ||
- | * insomnia and cardiac disease: | + | * insomnia and cardiac disease: |
- | * [[http:// | + | * [[https:// |
* | * | ||
* | * | ||
- | * Where should this go? http:// | + | * Where should this go? https:// |
* Diseases to add: autism... | * Diseases to add: autism... | ||
* Legacy content | * Legacy content | ||
Line 558: | Line 545: | ||
< | < | ||
- | * [[http:// | + | * [[https:// |
- | * [[http:// | + | * [[https:// |
</ | </ | ||
< | < | ||
- | http:// | + | https:// |
Line 590: | Line 577: | ||
< | < | ||
- | http:// | + | https:// |
Lancet Neurol. 2009 Nov; | Lancet Neurol. 2009 Nov; | ||
Line 618: | Line 605: | ||
The authors noted that their study adds to the literature because it took a novel approach, studying an entire population to examine the association between rheumatologic diseases and neuropsychiatric disorders. | The authors noted that their study adds to the literature because it took a novel approach, studying an entire population to examine the association between rheumatologic diseases and neuropsychiatric disorders. | ||
</ | </ | ||
- | ===== References ===== | + | ===== References =====</ |